Press Releases

Dyadic’s AlternaFuel® CMAX™ verified at SEKAB’s demonstration plant in Örnsköldsvik,

Sweden for more efficient production of biofuels and bio-based chemicals

JUPITER, Fla., September 24, 2012 – Dyadic International, Inc. (OTC Pink: DYAI), a global biotechnology company focused on the discovery, development, manufacture and sale of enzymes and other proteins for the bioenergy, bio-based chemicals, biopharmaceutical and industrial enzyme industries, announced today the results of its cooperation with SEKAB E-Technology on verifying effective enzymes for the degradation of cellulose into fermentable sugars as part of the recently concluded DISCO research project.

Dyadic’s research and development center in the Netherlands along with SEKAB E-Technology participated in the DISCO project, a four year EU-funded research project conducted by a consortium of research institutes, universities and industrial partners from across Europe as well as Russia. The goal of the DISCO project was to identify and develop more productive and cost-effective enzymes for the production of bioethanol from lignocellulosic raw materials, a research area that is attracting considerable interest worldwide. As part of the DISCO project, Dyadic’s biofuels enzyme, AlternaFuel® CMAX™ was successfully verified by SEKAB in the ethanol demonstration plant in Örnsköldsvik, Sweden.

“SEKAB has the expertise required to show if the results that we have seen at lab scale also work on a larger scale,” said Jan Wery, Research Director at Dyadic Netherlands. “Such experiments are essential to show our customers the maturity and scalability of our newly developed lignocellulosic enzymes. The enzyme industry is growing rapidly, partly because of the increasing demand for lignocellulosic biofuels, and we are working continuously to offer new, more efficient products at lower prices.”

Thore Lindgren,” Executive Vice President of SEKAB E-Technology stated, “The goal for SEKAB E-Technology is to translate the knowledge and experience gained at the plant over the years into commercial ventures. The ethanol demonstration plant is a unique facility and the expertise gathered here allows us to test all the aspects of cellulose degradation in a way that few others can.”

Cellulose is the main component in a variety of biomass, including waste from agriculture, forestry, wood-based industries and municipal solid waste. These materials which exist today in large quantities across the globe are renewable, do not compete with food production and can be converted into fermentable sugars for use in the production of second generation biofuels, bio-based chemicals and other bio-based products.


Dyadic International, Inc. is a global biotechnology company that uses its patented and proprietary technologies to conduct research, development and commercial activities for the discovery, development, manufacture and sale of enzymes and other proteins for the bioenergy, bio-based chemicals, biopharmaceutical and industrial enzyme industries.

Dyadic utilizes an integrated technology platform based on its patented and proprietary C1 fungus, which enables the development and large scale manufacture of low cost enzymes and other proteins for diverse market opportunities. The C1 platform technology can also be used to screen for the discovery of novel genes and proteins. Dyadic actively pursues licensing arrangements and other commercial opportunities to leverage the value of these technologies by providing its partners and collaborators with the benefits of manufacturing and/or utilizing the enzymes which these technologies help produce.


Based in Örnsköldsvik, Sweden, SEKAB is one of Sweden’s largest cleantech companies and one of Europe’s leading producers of ethanol. SEKAB imports, produces and refines bioethanol for fossil-free green chemicals and biofuels and also develops next-generation ethanol processes based on renewable raw materials.

SEKAB E-Technology is one of the few companies with the ability to test innovations within the biofuels field on a scale that is readily transferable to industrial production scale.


Certain statements contained in this press release are forward- looking statements. These forward-looking statements involve risks and uncertainties that could cause Dyadic’s actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. Except as required by law, Dyadic expressly disclaims any intent or obligation to update any forward-looking statements.


Dyadic International, Inc.

Adam J. Morgan, Esq.

Vice President General Counsel & Business Development

Phone: 561-743-8333